Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

被引：892

作者：

Fearon, Kenneth C. H. ^{[1
]}

Glass, David J. ^{[2
]}

Guttridge, Denis C. ^{[3
]}

机构：

[1] Univ Edinburgh, Royal Infirm, Sch Clin Sci & Community Hlth, Edinburgh EH16 4SA, Midlothian, Scotland

[2] Novartis Inst Biomed Res, Cambridge, MA 02139 USA

[3] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA

来源：

CELL METABOLISM | 2012年 / 16卷 / 02期

关键词：

SKELETAL-MUSCLE ATROPHY; TUMOR-NECROSIS-FACTOR; ACUTE-PHASE RESPONSE; UBIQUITIN LIGASE ATROGIN1/MAFBX; ADIPOSE TRIGLYCERIDE LIPASE; PROTEOLYSIS INDUCING FACTOR; FOXO TRANSCRIPTION FACTORS; SYNTHASE KINASE 3-BETA; MESSENGER-RNA LEVELS; KAPPA-B ACTIVATION;

D O I：

10.1016/j.cmet.2012.06.011

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Cancer cachexia is characterized by a significant reduction in body weight resulting predominantly from loss of adipose tissue and skeletal muscle. Cachexia causes reduced cancer treatment tolerance and reduced quality and length of life, and remains an unmet medical need. Therapeutic progress has been impeded, in part, by the marked heterogeneity of mediators, signaling, and metabolic pathways both within and between model systems and the clinical syndrome. Recent progress in understanding conserved, molecular mechanisms of skeletal muscle atrophy/hypertrophy has provided a downstream platform for circumventing the variations and redundancy in upstream mediators and may ultimately translate into new targeted therapies.

引用

页码：153 / 166

页数：14

共 50 条

[21] Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?
Nogueira-Ferreira, Rita
Sousa-Nunes, Fabio
Leite-Moreira, Adelino
Moreira-Costa, Liliana
Vitorino, Rui
Santos, Lucio Lara
Moreira-Goncalves, Daniel
Ferreira, Rita
INFLAMMATION RESEARCH, 2022, 71 (7-8) : 771 - 783
[22] Cancer cachexia
Michael J. Tisdale
Langenbeck's Archives of Surgery, 2004, 389 : 299 - 305
[23] Cancer cachexia
Tisdale, MJ
LANGENBECKS ARCHIVES OF SURGERY, 2004, 389 (04) : 299 - 305
[24] PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia
Pin, Fabrizio
Novinger, Leah J.
Huot, Joshua R.
Harris, Robert A.
Couch, Marion E.
O'Connell, Thomas M.
Bonetto, Andrea
FASEB JOURNAL, 2019, 33 (06) : 7778 - 7790
[25] Cancer Cachexia: Mechanisms and Clinical Implications
Donohoe, Claire L.
Ryan, Aoife M.
Reynolds, John V.
GASTROENTEROLOGY RESEARCH AND PRACTICE, 2011, 2011
[26] Molecular and neuroendocrine mechanisms of cancer cachexia
Mendes, Maria Carolina S.
Pimentel, Gustavo D.
Costa, Felipe O.
Carvalheira, Jose B. C.
JOURNAL OF ENDOCRINOLOGY, 2015, 226 (03) : R29 - R43
[27] Cancer cachexia
Tisdale, Michael J.
CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (02) : 146 - 151
[28] Cancer cachexia's metabolic signature in a murine model confirms a distinct entity
Der-Torossian, Hirak
Asher, Scott A.
Winnike, Jason H.
Wysong, Ashley
Yin, Xiaoying
Willis, Monte S.
O'Connell, Thomas M.
Couch, Marion E.
METABOLOMICS, 2013, 9 (03) : 730 - 739
[29] Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways
Tang, Cong
Zhu, Guodong
CURRENT STEM CELL RESEARCH & THERAPY, 2019, 14 (03) : 219 - 225
[30] SIGNALING PATHWAYS AND MEDIATORS IN LPS-INDUCED LUNG INFLAMMATION IN DIABETIC RATS: ROLE OF INSULIN
Martins, Joilson O.
Ferracini, Matheus
Anger, Denise B. C.
Martins, Daniel O.
Ribeiro, Luciano F., Jr.
Sannomiya, Paulina
Jancar, Sonia
SHOCK, 2010, 33 (01): : 76 - 82

← 1 2 3 4 5 →